Blood cancer’s genetic warning signs may appear years early
A long-term genetic study has identified DNA markers that can predict the progression of chronic blood cancers years before symptoms appear. These findings could allow for earlier intervention and more personalized treatment plans for patients with myeloproliferative neoplasms.
Long-term tracking of chronic blood cancers has revealed major genetic differences between patients whose conditions remain stable and those whose diseases eventually become more severe. The findings suggest that DNA changes may help doctors improve diagnoses, monitor patients more accurately, assess how treatments are working, and identify signs of progression years before symptoms become obvious.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in